Authors:
ROCHES AD
PARADIS L
KNANI J
HEJJAOUI A
DHIVERT H
CHANEZ P
BOUSQUET J
Citation: Ad. Roches et al., IMMUNOTHERAPY WITH A STANDARDIZED DERMATOPHAGOIDES-PTERONYSSINUS EXTRACT .5. DURATION OF THE EFFICACY OF IMMUNOTHERAPY AFTER ITS CESSATION, Allergy, 51(6), 1996, pp. 430-433
Authors:
BOUSQUET J
KNANI J
HENRY C
LIARD R
RICHARD A
MICHEL FB
NEUKIRCH F
Citation: J. Bousquet et al., UNDER-TREATMENT IN A NONSELECTED POPULATION OF ADULT PATIENTS WITH ASTHMA, Journal of allergy and clinical immunology, 98(3), 1996, pp. 514-521
Authors:
ROCHES AD
PARADIS L
KNANI J
HEJJAOUI A
DHIVERT H
MICHEL FB
BOUSQUET J
Citation: Ad. Roches et al., DURATION OF EFFICACY OF SPECIFIC IMMUNOTHERAPY (SIT) WITH DERMATOPHAGOIDES-PTERONYSSINUS (DER-P) EXTRACT AFTER ITS CESSATION IS RELATED TO SKIN-TEST REACTIVITY, Journal of allergy and clinical immunology, 97(1), 1996, pp. 202-202
Authors:
DESROCHES A
PARADIS L
KNANI J
HEJJAOUI A
DHIVERT H
MICHEL FB
BOUSQUET J
Citation: A. Desroches et al., SPECIFIC IMMUNOTHERAPY PREVENTS THE ONSET OF NEW SENSITIZATIONS IN MONOSENSITIZED CHILDREN, Journal of allergy and clinical immunology, 95(1), 1995, pp. 309-309
Authors:
BOUSQUET J
KNANI J
DHIVERT H
RICHARD A
CHICOYE A
WARE JE
MICHEL FB
Citation: J. Bousquet et al., QUALITY-OF-LIFE IN ASTHMA .1. INTERNAL CONSISTENCY AND VALIDITY OF THE SF-36 QUESTIONNAIRE, American journal of respiratory and critical care medicine, 149(2), 1994, pp. 371-375
Authors:
BOUSQUET J
KNANI J
HEJJAOUI A
FERRANDO R
COUR P
DHIVERT H
MICHEL FB
Citation: J. Bousquet et al., HETEROGENEITY OF ATOPY .1. CLINICAL AND IMMUNOLOGICAL CHARACTERISTICSOF PATIENTS ALLERGIC TO CYPRESS POLLEN, Allergy, 48(3), 1993, pp. 183-188